K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

2
Player Avatar acts20 (37.40) Submitted: 11/4/2011 3:57:11 PM : Outperform Start Price: $1.01 KV-A Score: +50.58

Very important new drug could save millions on premies..should be a standard for high risk women

Featured Broker Partners


Advertisement